Page last updated: 2024-09-03

imatinib mesylate and Anaphylactic Reaction

imatinib mesylate has been researched along with Anaphylactic Reaction in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Finkelman, F; Hogan, SP; Koleske, AJ; Noah, T; Waggoner, L; Wu, D; Yamani, A	1
Beaven, MA; Gilfillan, AM; Iwaki, S; Jensen, BM; Metcalfe, DD	1
Kano, Y	1

Reviews

1 review(s) available for imatinib mesylate and Anaphylactic Reaction

Article	Year
[Adverse drug reactions induced by molecular target therapy]. Arerugi = [Allergy], 2007, Volume: 56, Issue:12 Topics: Anaphylaxis; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzamides; Cetuximab; Communicable Diseases; ErbB Receptors; Etanercept; Fusion Proteins, bcr-abl; Gefitinib; Humans; Imatinib Mesylate; Immunoglobulin G; Infliximab; Lung Diseases; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Receptors, Tumor Necrosis Factor; Skin Diseases; Tumor Necrosis Factor-alpha	2007

Article

Year

[Adverse drug reactions induced by molecular target therapy].

Arerugi = [Allergy], 2007, Volume: 56, Issue:12

Topics: Anaphylaxis; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzamides; Cetuximab; Communicable Diseases; ErbB Receptors; Etanercept; Fusion Proteins, bcr-abl; Gefitinib; Humans; Imatinib Mesylate; Immunoglobulin G; Infliximab; Lung Diseases; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Receptors, Tumor Necrosis Factor; Skin Diseases; Tumor Necrosis Factor-alpha

2007

Other Studies

2 other study(ies) available for imatinib mesylate and Anaphylactic Reaction

Article	Year
The vascular endothelial specific IL-4 receptor alpha-ABL1 kinase signaling axis regulates the severity of IgE-mediated anaphylactic reactions. The Journal of allergy and clinical immunology, 2018, Volume: 142, Issue:4 Topics: Allergens; Anaphylaxis; Animals; Antibodies; Cell Line; Endothelium, Vascular; Female; Histamine; Humans; Imatinib Mesylate; Immunoglobulin E; Interleukin-4; Male; Mice, Inbred BALB C; Mice, Transgenic; Ovalbumin; Proto-Oncogene Proteins c-abl; Receptors, Interleukin-4; Shock	2018
Concurrent inhibition of kit- and FcepsilonRI-mediated signaling: coordinated suppression of mast cell activation. The Journal of pharmacology and experimental therapeutics, 2008, Volume: 324, Issue:1 Topics: Anaphylaxis; Animals; Benzamides; Calcium; Cell Degranulation; Cells, Cultured; Cytokines; Humans; Imatinib Mesylate; Immunoglobulin E; Mast Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Piperazines; Pyrimidines; Receptors, IgE; Stem Cell Factor; Zearalenone	2008

Article

Year

The vascular endothelial specific IL-4 receptor alpha-ABL1 kinase signaling axis regulates the severity of IgE-mediated anaphylactic reactions.

The Journal of allergy and clinical immunology, 2018, Volume: 142, Issue:4

Topics: Allergens; Anaphylaxis; Animals; Antibodies; Cell Line; Endothelium, Vascular; Female; Histamine; Humans; Imatinib Mesylate; Immunoglobulin E; Interleukin-4; Male; Mice, Inbred BALB C; Mice, Transgenic; Ovalbumin; Proto-Oncogene Proteins c-abl; Receptors, Interleukin-4; Shock

2018

Concurrent inhibition of kit- and FcepsilonRI-mediated signaling: coordinated suppression of mast cell activation.

The Journal of pharmacology and experimental therapeutics, 2008, Volume: 324, Issue:1

Topics: Anaphylaxis; Animals; Benzamides; Calcium; Cell Degranulation; Cells, Cultured; Cytokines; Humans; Imatinib Mesylate; Immunoglobulin E; Mast Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Piperazines; Pyrimidines; Receptors, IgE; Stem Cell Factor; Zearalenone

2008